Mood Disorders News

An electronic health record-based suicide risk prediction modeling approach detected risk for suicidal behavior among patients across independent health care systems, according to results of a prognostic study published in JAMA Network Open.

Researchers observed significant racial and ethnic differences in late-life depression severity, item-level symptom burden and depression care among older adults after adjusting for numerous confounders, according to results of a cross-sectional study published in JAMA Network Open.

The ongoing COVID-19 pandemic will likely present mental health challenges for children, according to child health experts who participated in a live panel discussion organized by Newswise.

Cross-generational bipolar disorder transmission appeared to be caused largely by genes, with rearing effects having a modest role, according to results of an extended Swedish national adoption study published in JAMA Psychiatry.

Effect sizes of psychotherapies differed by patient age, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.

Persistent sleep difficulties during the first year of life appeared associated with heightened risk for developing childhood anxieties and emotional disorders at age 10 years, according to results of a longitudinal study conducted in Australia and published in Archives of Disease in Childhood.

The FDA granted breakthrough device designation to the NeuroStar Advanced Therapy System for the treatment of bipolar depression, according to a press release from Neuronetics Inc., the device’s manufacturer.

Major depressive disorder exhibits spatially convergent structural and functional brain abnormalities, suggesting replicable neuroimaging features associated with the disorder, according to results of a meta-analysis published in American Journal of Psychiatry. This association goes beyond the transdiagnostic effects reported in previous meta-analyses and supports research focused on brain regions linked to depression, researchers noted.

The current body of research regarding psychedelics has produced insufficient evidence to recommend FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders, according to study findings published in American Journal of Psychiatry. However, researchers noted the need to further study the efficacy of psychedelics for treating psychiatric disorders.

With mental health issues becoming more prevalent on college campuses, researchers are working to help students more easily obtain mental health care by developing a wearable continuous monitoring tool.